AzTrials
AzTrials

ParodontitisBACTERIOBNCT02853734

Inflammatory Status of Visceral Adipose Tissue in Obese Patients Related to Periodontitis Severity

A study testing SEVERE PERIODONTITIS and NO PERIODONTITIS in people with Parodontitis and Obesity, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The research aims to compare the inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitis, in order to establish a potential causal link between the severity of the bacterial contamination and insulin resistance. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Parodontitis, Obesity, Metabolism Disorders
What is being tested?
SEVERE PERIODONTITIS and NO PERIODONTITIS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
122 participants
Where
1 siteReunion
Study dates
12 Mar 2019to Jul 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient eligible for bariatric surgery scheduled within the digestive surgery
  • Patient affiliated to Social Security system or equivalent

Who cannot join

  • Treatment with steroids or anti-inflammatory drugs in progress (or stopped for less than one month)
  • Patients who received antibiotics within 3 months prior to the bariatric surgery for whatever duration
  • Dental current (or older than 3 months)
  • Participation in another research protocol

Trial locations and contacts

1 site in 1 country.

Reunion1 site, 1 recruiting
  • CHU de La Réunion

    Saint-Pierre, 97448

    Nathalie LE-MOULLEC, MD, +262(0)262359164, nathalie.lemoullec@chu-reunion.fr

    Nathalie LE MOULLEC, MD

    Recruiting

Other trials in Reunion

About this study

Official title: Comparative Evaluation of the Inflammatory Status of Visceral Adipose Tissue From Obese Patients According to the Presence and Severity of Periodontitis

The research aims to compare the inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitis, in order to establish a potential causal link between the severity of the bacterial contamination and insulin resistance.

Read the detailed description

Recruitment of patients will be achieved in the department of digestive surgery. It will involve 122 patients with severe obesity undergoing bariatric surgery scheduled within the digestive surgery department. Patients recruited will be examined for evaluating the presence and severity of periodontitis, and separated into either group 1: for patients with moderate or severe periodontitis, and or group 2: for patients without or with mild periodontitis. The day before the surgery, blood sample will be collected for the analysis of circulating metabolic and inflammatory markers. Collection of stimulated saliva, periodontal sample and faeces samples (50 g) will also be carried out for bacteria determination. During the surgical procedure, a sample of visceral adipose tissue (50 g) will be collected and used for periodontal bacteria detection and inflammatory markers analyses.

Being tested
SEVERE PERIODONTITIS, NO PERIODONTITIS
Medical subject headings
Dry Socket, Obesity, Metabolic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SEVERE PERIODONTITISOther

    Patients exhibiting moderate to severe periodontitis

  • NO PERIODONTITISOther

    Patients without existing periodontitis or exhibiting mild periodontitis

Study groups in NCT02853734
Study groupRoleWhat they receive
SEVERE PERIODONTITISExperimentalPeriodontal examination Biological samples collection: periodontal, saliva, blood, fecal, visceral adipose tissue
Receives: Other: SEVERE PERIODONTITIS
NO PERIODONTITISOtherPeriodontal examination Biological samples collection: periodontal, saliva, blood, fecal, visceral adipose tissue
Receives: Other: NO PERIODONTITIS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitis

    Measurements of major adipocytokines (Interleukine 6, Leptin, Adiponectin, Tumor Necrosis Factor-alpha, Monocyte Chemoattractant Protein-1, macrophage F4/80 receptor, CD11c, nuclear factor-kappa B, Toll Like Receptor 2/4 )

    Measured: Consecutively to visceral fat biopsy (day of surgery)

Secondary outcomes (4)
  1. Detection of DNA for at least one type of periodontal pathogens in adipose tissue

    Aggregatibacter actinomycetemcomitans, Fusibacterium nucleatum, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola and Tannerella forsythia

    Measured: Consecutively to visceral fat biopsy (day of surgery)

  2. Description of the metabolic profile of patients relative to periodontitis severity

    glycemia, insulinemia, glucose tolerance, plasma and HDL total cholesterol, triglycerides

    Measured: Consecutively to periodontal examination (day before surgery)

  3. Link between adipose tissue inflammatory status, bacterial contamination and metabolic profile of patients

    adipose tissue inflammatory status, periodontal bacterial contamination,diabetic disorders, lipid metabolic profile of patients

    Measured: Consecutively to periodontal examination and fat biopsy (day before surgery, day of surgery)

  4. Link between the presence of periodontal pathogens in adipose tissue and their detection in saliva and plasma

    Detection of antibodies directed to periodontal bacteria in saliva and plasma

    Measured: Consecutively to periodontal examination and fat biopsy (day before surgery, day of surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2016 (estimated)
  2. Study start12 Mar 2019
  3. Primary completionJul 2020 (estimated)
  4. Study completionJul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
122 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02853734
Sponsor's protocol ID
2015/CHU/13
Acronym
BACTERIOB
Status last verified
Mar 2020
First submitted
26 Jul 2016
Last updated
4 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SEVERE PERIODONTITIS and NO PERIODONTITIS in people with Parodontitis and Obesity, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Reunion. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Emilie TECHER (+262(0)262906289, emilie.techer@chu-reunion.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inflammatory status of visceral adipose tissue from obese patients depending on the presence and severity of periodontitis (time frame: Consecutively to visceral fat biopsy (day of surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in